| The continued advance of vaccine adjuvants–‘we can work it out’ DT O’Hagan, RN Lodaya, G Lofano Seminars in immunology 50, 101426, 2020 | 96 | 2020 |
| “World in motion”–emulsion adjuvants rising to meet the pandemic challenges DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano npj Vaccines 6 (1), 158, 2021 | 53 | 2021 |
| Formulation design, optimization and in vivo evaluations of an α-tocopherol-containing self-emulsified adjuvant system using inactivated influenza vaccine RN Lodaya, AP Kanitkar, K Friedrich, D Henson, R Yamagata, S Nuti, ... Journal of controlled release 316, 12-21, 2019 | 23 | 2019 |
| Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant Y Wen, HV Trinh, CE Linton, C Tani, N Norais, DA Martinez-Guzman, ... PLoS One 13 (4), e0194266, 2018 | 15 | 2018 |
| Stable nanoemulsions for the delivery of small molecule immune potentiators RN Lodaya, LA Brito, TYH Wu, AT Miller, GR Otten, M Singh, DT O'Hagan Journal of Pharmaceutical Sciences 107 (9), 2310-2314, 2018 | 13 | 2018 |
| Overview of vaccine adjuvants RN Lodaya, S Gregory, MM Amiji, DT O'Hagan Practical Aspects of Vaccine Development, 9-25, 2022 | 6 | 2022 |
| Practical aspects of vaccine development P Kolhe, S Ohtake Academic Press, 2021 | 4 | 2021 |
| Lyophilized vaccine development NM Payton, RN Lodaya, AM Padilla Practical Aspects of Vaccine Development, 297-327, 2022 | 2 | 2022 |
| A Self-Emulsified Adjuvant System Containing the Immune Potentiator Alpha Tocopherol Induces Higher Neutralizing Antibody Responses than a Squalene-Only Emulsion When Evaluated … RN Lodaya, AP Kanitkar, A Ashraf, D Bamba, MM Amiji, DT O’Hagan Pharmaceutics 15 (1), 238, 2023 | 1 | 2023 |
| Nanoscale Vaccines for Influenza S Bhangde, RN Lodaya, MM Amiji Nanomedicines for the Prevention and Treatment of Infectious Diseases, 331-347, 2023 | | 2023 |
| " World in motion"-emulsion adjuvants rising to meet the pandemic challenges (Vol 6, 158, 2021) DT O'Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano NPJ VACCINES 8 (1), 2023 | | 2023 |
| Author Correction:“World in motion”–emulsion adjuvants rising to meet the pandemic challenges DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano npj Vaccines 8, 2023 | | 2023 |
| Review 2:" A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability" HM Niknam, NS Savar The MIT Press, 2022 | | 2022 |
| Oil/surfactant mixtures for self-emulsification R Lodaya, M Amiji, D O'hagan US Patent App. 17/423,927, 2022 | | 2022 |
| Self-Emulsifying Adjuvant Systems Containing Alpha-Tocopherol for Subunit Vaccines RN Lodaya Northeastern University, 2019 | | 2019 |
| Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant. WYX Wen YingXia, HV Trinh, CE Linton, C Tani, N Norais, ... | | 2018 |
Derek T O'HaganGSKVerified email at gsk.com
